Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas
Modeling patient-individual resistance to immunotherapy is challenging. Here, the authors use a syngeneic experimental hypermutated orthotopic glioma model to define radiological and biological features that can predict or explain the mechanistic differences between responders and non-responders to...
Guardado en:
Autores principales: | Katrin Aslan, Verena Turco, Jens Blobner, Jana K. Sonner, Anna Rita Liuzzi, Nicolás Gonzalo Núñez, Donatella De Feo, Philipp Kickingereder, Manuel Fischer, Ed Green, Ahmed Sadik, Mirco Friedrich, Khwab Sanghvi, Michael Kilian, Frederik Cichon, Lara Wolf, Kristine Jähne, Anna von Landenberg, Lukas Bunse, Felix Sahm, Daniel Schrimpf, Jochen Meyer, Allen Alexander, Gianluca Brugnara, Ralph Röth, Kira Pfleiderer, Beate Niesler, Andreas von Deimling, Christiane Opitz, Michael O. Breckwoldt, Sabine Heiland, Martin Bendszus, Wolfgang Wick, Burkhard Becher, Michael Platten |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/65441a7f16a24904a9e706ac1ace56b2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hypermutated phenotype in gliosarcoma of the spinal cord
por: Christopher S. Hong, et al.
Publicado: (2021) -
Ecology and molecular targets of hypermutation in the global microbiome
por: Simon Roux, et al.
Publicado: (2021) -
Glioblastoma multiforme restructures the topological connectivity of cerebrovascular networks
por: Artur Hahn, et al.
Publicado: (2019) -
Dietary tryptophan links encephalogenicity of autoreactive T cells with gut microbial ecology
por: Jana K. Sonner, et al.
Publicado: (2019) -
Targeting of somatic hypermutation by immunoglobulin enhancer and enhancer-like sequences.
por: Jean-Marie Buerstedde, et al.
Publicado: (2014)